Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

Helsinn Therapeutics names Paul Rittman as CEO

He replaces William Mann, who stepped down on 28 February

- PMLiVE

Concept Life Sciences adds to its scientific and commercial team

Dr Calvert and Dr Donaldson join the company to support growth

- PMLiVE

NCCN bolsters its Oncology Research Programme

Uses iEnvision to manage the programme’s projects

- PMLiVE

Fresenius says Akorn investigation could affect takeover

External ‘experts’ are investigating alleged breaches of data integrity requirements

Celgene building

FDA turns down Celgene’s filing for multiple sclerosis drug

The application needs additional pharmacology information according to the US agency

- PMLiVE

Mereo BioPharma appoints head of patient access and commercial planning

Wills Hughes-Wilson joins the group from Sobi

- PMLiVE

Lynn Lewis joins Envigo

She becomes the CRO’s senior vice president of global sales

- PMLiVE

Vivid Medical Communications Supports the 10th Anniversary of Rare Diseases Day 2018

Vivid Medical Communications – a newly created rare diseases specialist agency and part of the successful Lucid Group of companies – is a proud supporter of Rare Diseases Day 2018.

Lucid Group Communications Limited

Rare Disease Day 2018: Five things you should know about rare diseases.

To help raise awareness for Rare Disease Day, Porterhouse Medical describes five interesting facts about rare diseases

Porterhouse Medical Group

- PMLiVE

The challenges of making genomics a reality for patients today, not tomorrow

Creating transformative medicines

Bridging pharma’s digital gap

Although still playing catch-up, the industry is being transformed by technology

Eli Lilly HQ

FDA backs earlier use of Lilly’s breast cancer drug Verzenio

Studies show the drug improves PFS when used with an aromatase inhibitor

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links